Interferon-α2a in the Treatment of Chronic Myeloid Leukemia: Results of the Spanish Group on Interferon-α2a in CML
- 1 January 1992
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Interferon-Alpha Produces Sustained Cytogenetic Responses in Chronic Myelogenous LeukemiaAnnals of Internal Medicine, 1991
- Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapyCancer, 1990
- Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemiaThe American Journal of Medicine, 1990
- Serum Cholesterol and Triglycerides in Hematological MalignanciesActa Haematologica, 1989
- Interferon alpha-2b as therapy for Ph'-positive chronic myelogenous leukemia: a study of 82 patients treated with intermittent or daily administrationBlood, 1988
- Hematologic Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon AlphaAin Chronic Myelogenous LeukemiaNew England Journal of Medicine, 1986
- α2-Interferon: erste Behandlungsergebnisse bei der chronischen myeloischen LeukämieDeutsche Medizinische Wochenschrift (1946), 1986
- Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemiaBlood, 1983